Studying 5HTP to manage asthma symptoms in kids
Treatments studied
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This Phase 2 study tests whether 5HTP can help regulate asthma in children and teens who have mild to moderate asthma linked to allergies. It may be an option if your symptoms are allergy-related and you can follow study visits and questionnaires.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 8 and 18 years old
- Have mild to moderate asthma (not severe)
- Have a positive allergy test (skin test or blood IgE)
- Weigh at least 70 lbs (32 kg)
- Not take certain asthma/allergy medicines: no SSRI antidepressants, no montelukast or zileuton, and no biologic asthma shots/infusions (like omalizumab, mepolizumab, benralizumab, or dupilumab)
- Score high enough on asthma/anxiety symptom questionnaires (CES-DC or SCARED) and be able to attend study visits
- You (and a parent/guardian, if needed) must be willing to sign consent to join
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if tezepelumab can help reduce severe asthma attacks in children ages 5 to 11. It compares the drug to a placebo (a dummy treatment) to see if it is safe and effective.
This study looks at how to control and treat asthma in children and teenagers. It may help find better ways to manage asthma symptoms and treatment.
This study tests a new inhaled medicine, ADO-5030, to see if it helps people with mild or moderate asthma when their airways narrow (bronchoconstriction). You will be asked to breathe in a substance that can trigger asthma symptoms, and the study will check if the medicine helps prevent or reduce that reaction.
This study tests an investigational medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with current treatments. The goal is to see if it can reduce asthma attacks and improve breathing.
This study looks at how asthma affects people in China and tries to find patterns that might help predict which treatments work best. If you have asthma and are between 18 and 75, you may be able to join.
This study tests a program called 'Asthma Link' to help children with asthma take their daily medicine more consistently. It is for children ages 5–14 whose asthma is not well controlled and who sometimes forget their medication.
Hear when a new Mild or Moderate Asthma With Allergic Sensitization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.